Back to companies

Shin Poong Pharm Co Ltd: Overview

Shin Poong Pharm Co Ltd (Shin Poong) is a pharmaceutical company that manufactures and markets pharmaceutical products and active pharmaceutical ingredients. Its product portfolio includes over-the-counter, cephalosporin, penicillin, gentrisone cream, tolvaptan, mosapride citrate, medical devices, pyramax, irbesartan, and praziquantel. Shin Poong develops medicines in tablets, capsules, injections, syrups, ampoules, and creams. The company manufactures products for treating malaria, cardiovascular, and bone-related diseases. It operates in Gyeonggi-do, Ansan-si, Banweol and Chungbuk-do, South Korea. Shin Poong is headquartered in Seoul, South Korea.

Gain a 360-degree view of Shin Poong Pharm Co Ltd and make more informed decisions for your business Gain a 360-degree view of Shin Poong Pharm Co Ltd and make more informed decisions for your business Contact Us
Headquarters South Korea

Address 161 Yeoksam Road, Gangnam-gu, Ansan, Seoul, 06246


Telephone 82 2 2189-3400

No of Employees 840

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange 019170 (KRX)

Revenue (2022) $153.4M -4.3% (2022 vs 2021)

EPS XYZ

Net Income (2022) XYZ -62% (2022 vs 2021)

Market Cap* $557.9M

Net Profit Margin (2022) XYZ -69.4% (2022 vs 2021)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Contact Us

Shin Poong Pharm Co Ltd premium industry data and analytics

280+

Marketed Drugs

Understand Shin Poong Pharm Co Ltd’s commercialized product portfolio to stay one step ahead of the market.

50+

Clinical Trials

Determine Shin Poong Pharm Co Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Catalyst Calendar

Proactively evaluate Shin Poong Pharm Co Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

11+

Pipeline Drugs

Identify which of Shin Poong Pharm Co Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

2

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

2

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Shin Poong Pharm Co Ltd’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services Brands
API's: Service: Clamoxin
Amlodipine Besylate Contract Manufacturing Services Lynactam
Choline Alposcerate Tazicef
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Shin Poong Pharm Co Ltd portfolio and identify potential areas for collaboration Understand Shin Poong Pharm Co Ltd portfolio and identify potential areas for collaboration Contact Us

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 New Products/Services In April, Admiles unveiled Lutein Zeaxanthin in 10 mm ultra-small mini capsules.
2023 New Products/Services In September, Admiles launched two new products, Fishbone Calcium Magnesium Vitamin D and Supercritical Altige Omega 3.
2022 Others In November, Shinpoong Pharmaceutical applied to the Ministry of Food and Drug Safety to change the clinical trial protocol for the global phase 3 clinical trial of Pyramax.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Contact Us
Image for loader

Competitor Comparison

Key Parameters Shin Poong Pharm Co Ltd Boryung Pharmaceutical Co Ltd Ildong Pharmaceutical Co Ltd Binex Co Ltd Kolon Life Science Inc
Headquarters South Korea South Korea South Korea South Korea South Korea
City Ansan Seoul Seoul Busan Seoul
State/Province Seoul - - Yeongnam -
No. of Employees 840 1,144 1,433 390 432
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Contact Us
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Contact Us
Executives
Name Position Board Since Age
Jeman Yoo Chief Executive Officer; Director Executive Board - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Shin Poong Pharm Co Ltd key executives to enhance your sales strategy Gain insight into Shin Poong Pharm Co Ltd key executives to enhance your sales strategy Contact Us
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward